Skip to main content
SpringerLink
Log in
Book cover

Aptamers pp 59–71Cite as

Aptamer: Apt System for Target-Specific Drug Delivery

  • Chapter
  • First Online:

  • 631 Accesses

Abstract

The delivery and binding of the therapeutic molecules like drugs, siRNAs and toxins to their specific target is a challenging task. Poor efficacy and off target binding are major problems associated with current approaches for targeted delivery of therapeutic molecules. Therefore, to avoid off target binding, target specific delivery systems are urgently required. Over the years, aptamers have become attractive molecules for targeted delivery of drugs. Aptamers are defined as small, single-stranded DNA/RNA or peptides which can bind to the specific targets with better affinity. The therapeutic molecules can either conjugate directly to the aptamers or along with some carrier molecules like liposomes, antibodies and nanoparticles to achieve specific targeted delivery. The present book chapter will focus on aptamer mediated target specific delivery of drugs, toxins and siRNAs- both direct conjugation with aptamer and in association with carriers.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Alibolandi M, Ramezani M, Sadeghi F, Abnous K, Hadizadeh F (2015) Epithelial cell adhesion molecule aptamer conjugated PEG–PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro. Int J Pharm 479:241–251

    Article  CAS  PubMed  Google Scholar 

  • Alshaer W, Hillaireau H, Vergnaud J, Ismail S, Fattal E (2015) Functionalizing liposomes with anti-CD44 aptamer for selective targeting of cancer cells. Bioconjug Chem 26:1307–1313

    Article  CAS  PubMed  Google Scholar 

  • Azhdarzadeh M, Atyabi F, Saei AA, Varnamkhasti BS, Omidi Y, Fateh M, Ghavami M, Shanehsazzadeh S, Dinarvand R (2016) Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer. Colloids Surf B: Biointerfaces 143:224–232

    Article  CAS  PubMed  Google Scholar 

  • Baek SE, Lee KH, Park YS, Oh DK, Oh S, Kim KS, Kim DE (2014) RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo. J Control Release 196:234–242. (CrossRef) (PubMed)

    Article  CAS  PubMed  Google Scholar 

  • Bagalkot V, Farokhzad OC, Langer R, Jon S (2006) An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl 45:8149–8152. (PubMed: 17099918)

    Article  CAS  PubMed  Google Scholar 

  • Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, Langer R, Farokhzad OC (2007) Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett 7:3065–3070. (PubMed: 17854227)

    Article  CAS  PubMed  Google Scholar 

  • Bleickardt E, Argiris A, Rich R, Blum K, McKeon A, Tara H, Zelterman D, Burtness B, Davies MJ, Murren JR (2002) Phase I dose escalation trial of weekly docetaxel plus irinotecan in patients with advanced cancer. Cancer Biol Ther 1:646–651. (PubMed: 12642688)

    Article  CAS  PubMed  Google Scholar 

  • Cao Z, Tong R, Mishra A, Xu W, Wong GC, Cheng J, Lu Y (2009) Reversible cell-specific drug delivery with aptamer-functionalized liposomes. Angew Chem Int Ed Engl 48:6494–6498. (CrossRef) (PubMed)

    Article  CAS  PubMed  Google Scholar 

  • Chang HI, Yeh MK (2012) Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine 7:49–60

    CAS  PubMed  Google Scholar 

  • Chu TC, Marks JW 3rd, Lavery LA, Faulkner S, Rosenblum MG, Ellington AD, Levy M (2006a) Aptamer:toxin conjugates that specifically target prostate tumor cells. Cancer Res 66:5989–5992. (PubMed: 16778167)

    Article  CAS  PubMed  Google Scholar 

  • Chu TC, Twu KY, Ellington AD, Levy M (2006b) Aptamer mediated siRNA delivery. Nucleic Acids Res 34:e73. (PubMed: 16740739)

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Das M, Duan W, Sahoo SK (2015) Multifunctional nanoparticle–EpCAM aptamer bioconjugates: a paradigm for targeted drug delivery and imaging in cancer therapy. Nanomed Nanotechnol Biol Med 11:379–389

    Article  CAS  Google Scholar 

  • Dassie JP, Liu XY, Thomas GS, Whitaker RM, Thiel KW, Stockdale KR, Meyerholz DK, McCaffrey AP, McNamara JO 2nd, Giangrande PH (2009) Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol 27:839–849. (PubMed: 19701187)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Davis ME, Chen ZG, Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–782. (PubMed: 18758474)

    Article  CAS  PubMed  Google Scholar 

  • Deng K, Hou Z, Li X, Li C, Zhang Y, Deng X et al (2015) Aptamer mediated up-conversion core/MOF shell nanocomposites for targeted drug delivery and cell imaging. Sci Rep 5:7851

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ (2008) Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A 105:17356–17361. https://doi.org/10.1073/pnas.0809154105

    Article  PubMed  PubMed Central  Google Scholar 

  • Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498. (PubMed: 11373684)

    Article  CAS  PubMed  Google Scholar 

  • Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822. (PubMed: 1697402)

    Article  CAS  PubMed  Google Scholar 

  • Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R (2006a) Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A 103:6315–6320. (PubMed: 16606824)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Farokhzad OC, Karp JM, Langer R (2006b) Nanoparticle-aptamer bioconjugates for cancer targeting. Expert Opin Drug Deliv 3:311–324. (PubMed: 16640493)

    Article  CAS  PubMed  Google Scholar 

  • Fickert H, Fransson IG, Hahn U (2006) Aptamers to small molecules. In: Klussmann S (ed) The aptamer handbook: functional oligonucleotides and their applications. Wiley-VCH, Weinheim, pp 94–115

    Chapter  Google Scholar 

  • Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811. (PubMed: 9486653)

    Article  CAS  PubMed  Google Scholar 

  • Gehl J, Boesgaard M, Paaske T, Jensen BV, Dombernowsky P (1996) Paclitaxel and doxorubicin in metastatic breast cancer. Semin Oncol 23:35–38. (PubMed: 8996596)

    CAS  PubMed  Google Scholar 

  • Gopinath SCB, Awazu K, Fujimaki M, Shimizu K, Shima T (2013) Observations of immuno-goldconjugatesoninfluenzavirusesusing waveguide-mode sensors. PLoS One 8:1–10. https://doi.org/10.1371/journal.pone.0069121

    Article  CAS  Google Scholar 

  • Herrmann A, Priceman SJ, Kujawski M, Xin H, Cherryholmes GA, Zhang W et al (2014) CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells. J Clin Invest 124:2977–2987

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hong Y, Lee E, Ku M, Suh JS, Yoon DS, Yang J (2016) Femto-molar detection of cancer marker-protein based on immunonanoplasmonics at single-nanoparticle scale. Nanotechnology 27:185103

    Article  PubMed  CAS  Google Scholar 

  • Hu Y, Duan J, Zhan Q, Wang F, Lu X, Da Yang X (2012) Novel muc1aptamer selectively delivers cytotoxic agentto cancer cells in vitro. PLoS One 7:e31970

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huang YF, Chang HT, Tan WH (2008) Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal Chem 80(3):567–572. (PubMed: 18166023)

    Article  CAS  PubMed  Google Scholar 

  • Huang YF, Shangguan D, Liu H, Phillips JA, Zhang X, Chen Y, Tan W (2009) Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem 10:862–868. (PubMed: 19253922)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jalalian SH, Taghdisi SM, Hamedani NS, Kalat SAM, Lavaee P, Zand Karimi M et al (2013) Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo. Eur J Pharm Sci 50:191–197

    Article  CAS  PubMed  Google Scholar 

  • Kang S, Hah SS (2014) Improved ligand binding by antibodyaptamer pincers. Bioconjug Chem 25:1421–1427

    Article  CAS  PubMed  Google Scholar 

  • Kang H, O’Donoghue MB, Liu H, Tan WA (2010) Liposome based nanostructure for aptamer directed delivery. Chem Commun (Camb) 46:249–251. (CrossRef) (PubMed)

    Article  CAS  Google Scholar 

  • Keefe AD, Pai S, Ellington A (2010) Aptamers as therapeutics. Nat Rev Drug Discov 9:537–550. (PubMed: 20592747)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim E, Jung Y, Choi H, Yang J, Suh JS, Huh YM, Kim K, Haam S (2010a) Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex. Biomaterials 31:4592–4599. (PubMed: 20206379)

    Article  CAS  PubMed  Google Scholar 

  • Kim D, Jeong YY, Jon S (2010b) A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 4:3689–3696. (PubMed: 20550178)

    Article  CAS  PubMed  Google Scholar 

  • Lale SV, Aswathy RG, Aravind A, Kumar DS, Koul V (2014) AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA−PCL−pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy. BioMacromoluecules ASAP 15:1737–1752

    Article  CAS  Google Scholar 

  • Leach JC, Wang A, Ye K, Jin S (2016) A RNA-DNA hybrid aptamer for nanoparticle-based prostate tumor targeted drug delivery. Int J Mol Sci 17. https://doi.org/10.3390/ijms17030380

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lee JH, Yigit MV, Mazumdar D, Lu Y (2010) Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates. Adv Drug Deliv Rev 62:592–605. (PubMed: 20338204)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC (2008) Nanotechnology and aptamers: applications in drug delivery. Trends Biotechnol 26:442–449. (PubMed: 18571753)

    Article  CAS  PubMed  Google Scholar 

  • Li N, Larson T, Nguyen HH, Sokolov KV, Ellington D (2010) Directed evolution of gold nanoparticle delivery to cells. Chem Commun (Camb) 46:392–394

    Article  Google Scholar 

  • Li L, Xiang D, Shigdar S, Yang W, Li Q, Lin J et al (2014a) Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells. Int J Nanomedicine 9:1083–1096

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Li C, Chen T, Ocsoy I, Zhu G, Yasun E, You M et al (2014b) Goldcoated Fe 3 O 4 nanoroses with five unique functions for cancer cell targeting, imaging, and therapy. Adv Funct Mater 24:1772–1780

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li L, Hou J, Liu X, Guo Y, Wu Y, Zhang L et al (2014c) Nucleolintargeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas. Biomaterials 35:3840–3850

    Article  CAS  PubMed  Google Scholar 

  • Li X, Yu Y, Ji Q, Qiu L (2015) Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles. Nanomedicine 11:175–184

    Article  CAS  PubMed  Google Scholar 

  • Liss M, Petersen B, Wolf H, Prohaska E (2002) An aptamer-based quartz crystal protein biosensor. Anal Chem 74:4488–4495. (PubMed: 12236360)

    Article  CAS  PubMed  Google Scholar 

  • Liu N, Zhou C, Zhao J, Chen Y (2012a) Reversal of paclitaxel resistance in epithelial ovarian carcinoma cells by a MUC1 aptamer-let-7i chimera. Cancer Investig 30:577–582

    Article  CAS  Google Scholar 

  • Liu Z, Duan J-H, Song Y-M, Ma J, Wang F-D, Lu X et al (2012b) Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro. J Transl Med 10:148

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu J, Wei T, Zhao J, Huang Y, Deng H, Kumar A, Wang C, Liang Z, Ma X, Liang XJ (2016) Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance. Biomaterials 91:44–56

    Article  CAS  PubMed  Google Scholar 

  • Lupold SE, Hicke BJ, Lin Y, Coffey DS (2002) Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 62:4029–4033. (PubMed: 12124337)

    CAS  PubMed  Google Scholar 

  • McMahon KS, Wieman TJ, Moore PH, Fingar VH (1994) Effects of photodynamic therapy using monoL-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response. Cancer Res 54:5374–5379. (PubMed: 7923168)

    CAS  PubMed  Google Scholar 

  • McNamara JO 2nd, Andrechek ER, Wang Y, Viles KD, Rempel RE, Gilboa E, Sullenger BA, Giangrande PH (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol 24:1005–1015. (PubMed: 16823371)

    Article  CAS  PubMed  Google Scholar 

  • Mello CC, Conte D Jr (2004) Revealing the world of RNA interference. Nature 431:338–342. (PubMed: 1537204)

    Article  CAS  PubMed  Google Scholar 

  • Meng L, Yang L, Zhao X, Zhang L, Zhu H, Liu C et al (2012) Targeted delivery of chemotherapy agents using a liver cancerspecific aptamer. PLoS One 7:e33434

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miller VA, Kris MG (2002) Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer. Semin Oncol 27:3–10. (PubMed: 10810932)

    Google Scholar 

  • Min K, Jo H, Song K, Cho M, Chun YS, Jon S, Kim WJ, Ban C (2011) Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (−) prostate cancers. Biomaterials 32:2124–2132. (PubMed: 21147500)

    Article  CAS  PubMed  Google Scholar 

  • Neff CP, Zhou J, Remling L, Kuruvilla J, Zhang J, Li H et al (2011) An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4+ T cell decline in humanized mice. Sci Transl Med 3:1–20

    Article  CAS  Google Scholar 

  • Nimjee SM, Rusconi CP, Sullenger BA (2006) Aptamers to proteins. In: Klussmann S (ed) The aptamer handbook: functional oligonucleotides and their applications. Wiley-VCH, Weinheim, pp 131–166

    Chapter  Google Scholar 

  • Pilapong C, Sitthichai S, Thongtem S, Thongtem T (2014) Smart magnetic nanoparticle-aptamer probe for targeted imaging and treatment of hepatocellular carcinoma. Int J Pharm 473:469–474

    Article  CAS  PubMed  Google Scholar 

  • Porciani D, Tedeschi L, Marchetti L, Citti L, Piazza V, Beltram F, Signore G (2015) Aptamer-mediated codelivery of doxorubicin and NF-κB decoy enhances chemosensitivity of pancreatic tumor cells. Mol Ther Nucleic Acids 4:e235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Qiu L, Chen T, Öçsoy I, Yasun E, Wu C, Zhu G et al (2015) A cell-targeted, size-photocontrollable, nuclear-uptake nanodrug delivery system for drug-resistant cancer therapy. Nano Lett 15:457–463

    Article  CAS  PubMed  Google Scholar 

  • Ray P, Cheek MA, Sharaf ML, Li N, Ellington AD, Sullenger BA et al (2012) Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells. Nucleic Acid Ther 22:295–305

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sayari E, Dinarvand M, Amini M, Azhdarzadeh M, Mollarazi E, Ghasemi Z et al (2014) MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery. Int J Pharm 473:304–315

    Article  CAS  PubMed  Google Scholar 

  • Sedletska Y, Giraud-Panis MJ, Malinge JM (2005) Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways. Curr Med Chem Anticancer Agents 5:251–265. (PubMed: 15992353)

    Article  CAS  PubMed  Google Scholar 

  • Shiao Y, Chiu H, Wu P, Huang Y (2014) Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery. ACS Appl Mater Interfaces 6:21832–21841

    Article  CAS  PubMed  Google Scholar 

  • Shieh YA, Yang SJ, Wei MF, Shieh MJ (2010) Aptamer-based tumor-targeted drug delivery for photodynamic therapy. ACS Nano 4:1433–1442. (PubMed: 20166743)

    Article  CAS  PubMed  Google Scholar 

  • Somasunderam A, Thiviyanathan V, Tanaka T, Li X, Neerathilingam M, Lokesh GLR et al (2010) Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44. Biochemistry 49:9106–9112

    Article  CAS  PubMed  Google Scholar 

  • Stirpe F, Olsnes S, Pihl A (1980) Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A. J Biol Chem 255:6947–6953. (PubMed: 7391060)

    CAS  PubMed  Google Scholar 

  • Stuart CH, Singh R, Smith TL, D’Agostino R Jr, Caudell D, Balaji KC, Gmeiner WH (2016) Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn2+ chelator TPEN inducing oxidative stress in prostate cancer cells. Nanomedicine (Lond) 11:1207–1222

    Article  CAS  Google Scholar 

  • Subramanian N, Raghunathan V, Kanwar JR, Kanwar RK, Elchuri SV, Khetan V et al (2012) Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer. Mol Vis 18:2783–2795

    CAS  PubMed  PubMed Central  Google Scholar 

  • Taber SW, Fingar VH, Coots CT, Wieman TJ (1998) Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a phase I clinical study. Clin Cancer Res 4:2741–2746. (PubMed: 9829737)

    CAS  PubMed  Google Scholar 

  • Taghdisi SM, Abnous K, Mosaffa F, Behravan J (2010) Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer. J Drug Target 18:277–281. (PubMed: 19943768)

    Article  CAS  PubMed  Google Scholar 

  • Toma S, Palumbo R, Sogno G, Venturino A, Santi L (1992) Doxorubicin (or epidoxorubicin) combined with ifosfamide in the treatment of adult advanced soft tissue sarcomas. Ann Oncol 3(Suppl 2):S119–S123. (PubMed: 1622853)

    Article  PubMed  Google Scholar 

  • Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510. (PubMed: 2200121)

    Article  CAS  PubMed  Google Scholar 

  • Visani G, Isidori A (2011) Doxorubicin variants for hematological malignancies. Nanomedicine (Lond) 6:303–306. (PubMed: 21385131)

    Article  CAS  Google Scholar 

  • Wang AZ, Bagalkot V, Vasilliou CC, Gu F, Alexis F, Zhang L et al (2008) Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. Chem Med Chem 3:1311–1315. (PubMed: 18613203)

    Article  CAS  PubMed  Google Scholar 

  • Wang K, Yao H, Meng Y, Wang Y, Yan X, Huang R (2015) Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy. Acta Biomater 16:196–205

    Article  CAS  PubMed  Google Scholar 

  • Wilner SE, Levy M (2016) Synthesis and characterization of aptamer-targeted SNALPs for the delivery of siRNA. Methods Mol Biol 1380:211–224

    Article  CAS  PubMed  Google Scholar 

  • Wullner U, Neef I, Eller A, Kleines M, Tur MK, Barth S (2008) Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. Curr Cancer Drug Targets 8:554–565. (PubMed: 18991566)

    Article  CAS  PubMed  Google Scholar 

  • Xiao Z, Levy-Nissenbaum E, Alexis F, Lupták A, Teply BA, Chan JM et al (2012) Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano 6:696–704. https://doi.org/10.1021/nn204165v

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xing H, Tang L, Yang X, Hwang K, Wang W, Yin Q et al (2013) Selective delivery of an anticancer drug with aptamerfunctionalized liposomes to breast cancer cells in vitro and in vivo. J Mater Chem B Mater Biol Med 1:5288–5297

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xu W, Siddiqui IA, Nihal M, Pilla S, Rosenthal K, Mukhtar H et al (2013) Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials 34:5244–5253

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ye M, Hu J, Peng M, Liu J, Liu J, Liu H, Zhao X, Tan W (2012) Generating aptamers by cell-SELEX for applications in molecular medicine. Int J Mol Sci 13:3341–3353

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yu C, Hu Y, Duan J, Yuan W, Wang C, Xu H, Yang XDA (2011a) Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro. PLoS One 6:1–8. https://doi.org/10.1371/journal.pone.0024077

    Article  CAS  Google Scholar 

  • Yu MK, Kim D, Lee IH, So JS, Jeong YY, Jon S (2011b) Imageguided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles. Small 7:2241–2249

    Article  CAS  PubMed  Google Scholar 

  • Zhang H, Hou L, Jiao X, Yandan J (2014) In vitro and in vivo evaluation of antitumor drug-loaded aptamer targeted singlewalled carbon nanotubes system. Curr Pharm Biotechnol 14(13):1105–1117. https://doi.org/10.2174/1389201015666140408123710

    Article  CAS  PubMed  Google Scholar 

  • Zhao N, You J, Zeng Z, Li C, Zu Y (2013) An ultra pH-sensitive and aptamer-equipped nanoscale drug-delivery system for selective killing of tumor cells. Small 9:3477–3484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhou J, Li H, Zhang J, Piotr S, Rossi J (2011) Development of cell type specific anti-HIV gp120 aptamers for siRNA delivery. J Vis Exp:1–9. https://doi.org/10.3791/2954

  • Zhou C, Chen T, Wu C, Zhu G, Qiu L, Cui C, Hou W, Tan W (2015) Aptamer-CaCO3 nanostructures: a facile, pH-responsive, specific platform for targeted anticancer theranostics. Chem Asian J 10:1199–1216

    Google Scholar 

  • Zhu Q, Shibata T, Kabashima T, Kai M (2012) Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA. Eur J Med Chem 56:396–399

    Article  CAS  PubMed  Google Scholar 

  • Zitzmann S, Mier W, Schad A, Kinscherf R, Askoxylakis V, Kramer S, Altmann A, Eisenhut M, Haberkorn U (2005) A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. Clin Cancer Res 11:139–146. (PubMed: 15671538)

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biotechnology, Central University of Haryana, Mahendergarh, Haryana, India

    Meenu Goyal &  Citu

  2. Institute of Advanced Study, Shenzhen University, Shenzhen, China

    Nidhi Singh

  3. TFSL, Dairy Microbiology Division, ICAR-National Dairy Research Institute, Karnal, Haryana, India

    Varsha Singla

  4. Regional Centre of Organic Farming, Department of Agriculture, Cooperation and Farmers Welfare, Ministry of Agriculture and Farmers Welfare, Bhubaneswar, Odisha, India

    Ankit Singla

Authors
  1. Meenu Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Citu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nidhi Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Varsha Singla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ankit Singla
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biotechnology, Central University of Haryana, Mahendergarh, Haryana, India

    Gulab Singh Yadav

  2. Department of Biotechnology, Maharishi Markandeswar University, Ambala, Haryana, India

    Vikas Kumar

  3. Department of Microbiology, Kurukshetra University, Kurukshetra, Haryana, India

    Neeraj K. Aggarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Goyal, M., Citu, Singh, N., Singla, V., Singla, A. (2019). Aptamer: Apt System for Target-Specific Drug Delivery. In: Yadav, G., Kumar, V., Aggarwal, N. (eds) Aptamers. Springer, Singapore. https://doi.org/10.1007/978-981-13-8836-1_4

Download citation

Publish with us

Policies and ethics

Search

Navigation